As per the latest data released by Transforming Access to Student Outcomes in Higher Education (TASO) and the Policy Institute at King's College London, the number of UK students reporting mental health difficulties tripled. The estimate reveals that around 300,000 students could now be experiencing mental health struggles. Of the total, 18% of students reported some kind of mental health issue in 2024.

As per the reports, this estimate is triple what was reported in 2017, where it was at 6%. Experts also say that Covid-19 pandemic is "often considered to have contributed to this, it does not explain the ongoing rise in mental health difficulties." Another reason could also be the "changing definition and increasing openness about mental health" which has led to a rise in numbers. The report notes, "This trend pre-dates the Covid-19 pandemic and the cost-of-living crisis. Although these factors play a part in students' deteriorating mental health, they cannot therefore be the only explanation."

How Did The Report Conclude?

The report drew data collected over the latest Student Academic Experience Survey of 93,212 students. From the survey, it was found that there exist significant disparities between demographic groups, with women being twice as likely to report mental health difficulties, about 22% as compared to men, at 11%.

What Did The Results Reveal?

The results revealed that students who identified as LGBTQ experienced the highest rates of mental health challenges. This has actually lessened the hope that conditions for LGBTQ students are improving, which may not have been a positive case.

Of them, 42% are bisexual and lesbian students, whereas last year it was 35% and 32% respectively. The report also noted that mental health difficulties among lesbian women and gay men rose three times the rate of straight people, and among bisexual and asexual people, it was twice as high. For trans students, the number jumped from 25% in 2023 to 40% in 2024.

Is The LGBTQ+ Prone To Mental Health Crisis?

As per the Child Mind Institute, being LGBTQ+ does not cause mental health problems, but because these kids often face factors like rejection, discrimination and violence, they are at a higher risk of challenges including depression, anxiety, and even attempting suicide.

A UTAH Health study quotes Anna Docherty, PhD, LP, assistant professor of psychiatry at Huntsman Mental Health Institute that, "likely with any identity, feeling different - or worse, unaccepted as you are is a significant risk factor of mental health struggle." The data reveals that LGBTQ+ teens are six times more likely to experience symptoms of depression than non-LGBTQ+ identifying teens. They are also more than twice as likely to feel suicidal and more than four times as likely to attempt suicide. In the US alone, 48% of transgender adults report that they have considered suicide in the last year, compared to 4% of the overall population.

What Do These Findings Mean?

TASO's academic lead and professor of public policy at King's College London, Michael Sanders said, "LGBTQ students and women bear the brunt of the rise in declining mental health and urgent action is needed to understand and address these trends."

According to the American Academy of Dermatology, skin cancer causes about 60,000 deaths every year globally. The current estimates also show that about one in five Americans is at risk of having the deadly disease in their lifetime. Though the technology of curing skin cancer is very advanced, the early detection of the disease is still a very crucial aspect in the path to getting a full cure.

And now, the researchers have come up with the smart tattoo technology, which can be a game-changer in this aspect.

A recent research study led by Professor Jinyang Liang from the Institut national de la recherche scientifique (INRS), an expert in ultrafast imaging and biophotonics, has shed light on promising smart tattoo technology that can aid in detecting skin cancer. The study was conducted in collaboration between the INRS in Québec and Université de Montréal.

The process that Professor Liang and his team have researched is Single-shot Microneedle-Encoded Upconversion Lifetime Mapping (SMEAR-ULM), which is a great leap forward in skin cancer detection.SMEAR-ULM monitors microscopic temperature changes on the skin surface that signal the pernicious transformations with unprecedented sensitivity.

Skin cancer is, without a doubt, one of the most deadly ailments known to man, and among its three types, melanoma is the most notorious one. Early detection in case of melanoma is very important for its cure. The current state of the treatment process depends heavily on visual examinations and invasive biopsies, which are known to cause discomfort for patients as well as occasional unnecessary interventions due to false positives, and SMEAR-ULM is a possible answer to these problems.

Read Also: Melanoma Is Being Overdiagnosed. Here's Everything You Should Know

Melanoma: The Deadliest Kind Of Skin Cancer

Melanoma is a type of skin cancer that develops in melanocytes, the cells responsible for producing melanin, the pigment that gives skin its colour. It can occur anywhere on the skin but often develops on areas exposed to the sun, such as the face, arms, back, and legs. Melanoma can also appear in less-exposed areas, like the soles of the feet, palms, or under the nails, particularly in individuals with darker skin tones. Although rare, melanoma may develop in the eyes, mouth, or internal organs.

Symptoms Of Melanoma

The primary sign of melanoma is a new or changing mole, freckle, or skin lesion. The "ABCDE rule" helps identify suspicious moles:

• Asymmetry: One half does not match the other.

• Border: Irregular or scalloped edges.

• Colour: Multiple shades or unusual colours like red, white, or blue.

• Diameter: Larger than 6 mm (about the size of a pencil eraser).

• Evolving: Changes in size, shape, or colour.

Additional symptoms may include itching, bleeding, or a sore that doesn’t heal. Prompt medical attention is essential for suspicious skin changes.

The suspected case of Ebola infection in a young woman in Bengaluru who had returned from Ebola-affected Uganda has tested negative, India's Ministry of Health & Family Welfare has confirmed.

The woman who arrived in Bengaluru from Kampala, Uganda, on May 23, was suspected of infection after developing mild symptoms, including body aches. She was shifted from a hotel to the state-run Epidemic Diseases Hospital on May 26, and her samples were sent to the National Institute of Virology in Pune.

"The test result has returned negative for Ebola Virus Disease," the Ministry said, adding that there is "no confirmed case of Ebola in India".

The Ministry said that although the woman remained healthy apart from a mild body ache, she was isolated and tested as part of the precaution measures instated in the country against the Ebola outbreak, which has so far affected over 900 people and led to more than 200 deaths in the Democratic Republic of Congo and Uganda. As per African health officials, 10 nations on the continent are at high risk.

WHO Says Ebola Spreading Rapidly

Also read: Russia's New Ebola Vaccine To Protect Against Rare Bundibugyo Strain, Says Health Minister

Dr. Rajeev Jayadevan, Co-Chairman of the National IMA COVID Task Force and Past President of the Indian Medical Association, Cochin, told HealthandMe, that the spread of the outbreak to other countries may not be surprising.

“With air travel being common and the outbreak already having spread to multiple countries in Africa, it is entirely possible for someone who had contact with a person with Ebola virus disease to get on a flight to another country,” Dr. Rajeev said.

“All patients with Ebola disease may not know they have it — as the initial symptoms are nonspecific, such as fever and body ache. In addition, scarcity of the exact PCR test to diagnose the latest Bundibugyo Ebola virus in Africa makes it possible to miss it entirely,” he added.

World Health Organization (WHO) chief Tedros Adhanom Ghebreyesus earlier stated he was “deeply concerned about the scale and speed of the epidemic”.

He added that the ongoing outbreak "is spreading rapidly" and "outpacing us".

The global health agency has also determined that the deadly outbreak is a “Public Health Emergency of International Concern (PHEIC)”.

India Boosts Surveillance

Read More: Why Ebola Outbreaks Keep Returning In Africa? | Explained

In view of the outbreak, the Ministry of Health, in coordination with the concerned State authorities, is maintaining close surveillance, and all necessary public health protocols are being followed in accordance with WHO guidelines.

The government said it "remains vigilant and prepared, with screening and surveillance measures continuing at all designated Points of Entry and across the public health system".

Citizens are advised not to panic, avoid spreading misinformation, and rely only on official sources for information.

The government also issued guidelines for passengers arriving from Ebola-affected countries. As part of the precautionary measures, travelers entering the country from such nations are required to undergo a 21-day quarantine period.

How Ebola Spreads

Ebola disease is a severe viral hemorrhagic fever with a high mortality rate.

Ebola spreads through:

• Direct contact with infected blood or bodily fluids

• Contact with contaminated surfaces or medical equipment

• Unsafe caregiving exposure

• Traditional burial practices involving direct contact

• Certain zoonotic animal exposures.

Symptoms to watch for include:

• fever,

• weakness,

• headache,

• muscle pain,

• vomiting,

• diarrhea,

• sore throat,

• unexplained bleeding.

Russia today claimed that its scientists have developed a novel vaccine against a new Ebola strain.

According to Russian Health Minister Murashko, "the vaccine may also protect against the rare Bundibugyo strain linked to the current outbreak in the DR Congo".

It is because the "genetic similarity between this virus variant and the vaccine strain is about 60-70%," Alexander Gintsburg, scientific director of the Gamaleya National Center of Epidemiology and Microbiology, was quoted as saying GxP News.

The vaccine, for which "clinical trials would take place, as per Anne Ancia, the WHO’s representative in the DRC, comes as a hope against the Bundibugyo strain, with no vaccine or antiviral available.

The strain has so far caused over 900 cases and more than 200 deaths in the Democratic Republic of the Congo and Uganda.

Earlier this week, Russia’s consumer health watchdog Rospotrebnadzor announced it would send specialists to Africa to help fight the Ebola outbreak, GxP News reported.

The country noted that it will also supply Russian-developed diagnostic tests.

Health Minister Murashko said he and WHO Director-General Tedros Adhanom Ghebreyesus had discussed the supply of Russian vaccines to the DRC and Uganda in the context of the Ebola outbreak.

“Specialists are already deploying to provide assistance. We discussed this with Dr Tedros, the head of the World Health Organisation,” Murashko said.

Gintsburg believes that "medical workers in outbreak zones should be vaccinated with the existing vaccine, even though no targeted efficacy tests against this strain have been conducted".

He also stressed the need to develop a separate vaccine against Bundibugyo. However, the institute does not yet have a sample of this pathogen.

“I believe the existing vaccine may confer immunity against this pathogen, though we have not tested it. In the absence of other means, it should be used,” he told Izvestia, a Russian Newspaper.

Ebola Vaccine From Developers Of COVID Shot

Scientists at Oxford University are also developing a new vaccine that could be ready for clinical trials within two to three months to help tackle the Ebola emergency.

The vaccine uses the same technology the team developed during the COVID pandemic. It is a highly adjustable technology - known as ChAdOx1 - that can be quickly tweaked so it works against different infections.

Another separate experimental Bundibugyo vaccine is also in development, but it is expected to take six to nine months for any dose of that to be ready for testing, BBC reported.

Ebola: An Antiviral On The Anvil

The WHO has also recommended prioritizing two monoclonal antibodies for clinical trials.

"We are also recommending the evaluation of the antiviral obeldesivir in a clinical trial as post-exposure prophylaxis for people who are high-risk contacts," the WHO chief said.

This clinical trial is now being developed jointly with Africa CDC and the Collaborative Open Research Consortium on filoviruses, he noted.

How Ebola Spreads

Ebola disease is a severe viral hemorrhagic fever with a high mortality rate.

Ebola spreads through:

• Direct contact with infected blood or bodily fluids

• Contact with contaminated surfaces or medical equipment

• Unsafe caregiving exposure

• Traditional burial practices involving direct contact

• Certain zoonotic animal exposures.

Symptoms to watch for includes:

• fever,

• weakness,

• headache,

• muscle pain,

• vomiting,

• diarrhea,

• sore throat,

• unexplained bleeding.